United Rail (URAL) 10-Q 17 Nov 14 2015 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Sep. 30, 2014	Nov. 14, 2014
Document and Entity Information:	'	'
Entity Registrant Name	'LAS VEGAS RAILWAY EXPRESS, INC.	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Amendment Flag	'false	'
Entity Central Index Key	'0001405227	'
Current Fiscal Year End Date	'--03-31	'
Entity Common Stock, Shares Outstanding	'	245,900,593
Entity Filer Category	'Smaller Reporting Company	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Well-known Seasoned Issuer	'No	'
Document Fiscal Year Focus	'2015	'
Document Fiscal Period Focus	'Q2	'

CONDENSED_BALANCE_SHEETS

CONDENSED BALANCE SHEETS (USD $)	Sep. 30, 2014	Mar. 31, 2014
ASSETS:	'	'
Cash	$4,575	$87,910
Accounts receivable	72,598	'
Prepayments and other	81,298	101,250
Total current assets	158,471	189,160
Property and equipment, net of accumulated depreciation	694,361	684,407
Other assets	'	'
Deposits	21,500	22,385
Total assets	874,332	895,952
Liabilities and Stockholders' Deficit	'	'
Short term notes payable	'	13,333
Accounts payable and accrued expenses	685,689	442,711
Derivative liability	2,013,742	1,198,018
Notes payable - related parties	59,000	'
Current portion of convertible notes payable, net of debt discount	2,568,598	1,271,984
Total current liabilities	5,327,029	2,926,046
Long-term portion of convertible debt, net of current portion	218,135	150,000
TOTAL LIABILITIES	5,545,164	3,076,046
Commitments and contingencies	'	'
Stockholders' deficit	'	'
Common stock, $0.0001 par value, 500,000,000 shares authorized, 61,044,915 and 16,041,142 shares issued and outstanding as of September 30, 2014 (unaudited) and March 31, 2014, respectively	6,104	1,604
Additional paid-in capital	33,896,010	29,445,945
Common stock payable	39,001	'
Accumulated deficit	-38,611,947	-31,627,643
Total stockholders' deficit	-4,670,832	-2,180,094
Total stockholders' deficit Total liabilities and stockholders' deficit	$874,332	$895,952

BALANCE_SHEET_PARENTHETICAL

BALANCE SHEET PARENTHETICAL (USD $)	Sep. 30, 2014	Mar. 31, 2014
CONDENSED BALANCE SHEETS	'	'
Common stock par value	$0.00	$0.00
Common stock shares authorized	500,000,000	500,000,000
Common stock shares issued	61,044,915	16,041,142
Common stock shares outstanding	61,044,915	16,041,142

CONDENSED_STATEMENT_OF_OPERATI

CONDENSED STATEMENT OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
CONDENSED STATEMENT OF OPERATIONS	'	'	'	'
Revenues	$105,010	'	$107,554	'
Cost of sales	50,547	'	52,544	'
Gross profit	54,463	'	55,010	'
Operating Expenses:	'	'	'	'
Compensation and payroll taxes	633,457	306,803	3,499,462	1,156,132
Selling, general and administrative	385,707	869,459	770,302	1,077,582
Professional fees	253,359	362,721	1,022,638	944,509
Depreciation expense	27,157	1,928	29,592	3,362
Total operating expenses	1,299,680	1,540,911	5,321,994	3,181,585
Loss from operations	-1,245,217	-1,540,911	-5,266,984	-3,181,585
Other income (expense)	'	'	'	'
Interest expense	-734,769	-1,013,666	-2,136,919	-3,535,293
Change in derivative liability	-450,597	3,959,890	419,602	4,910,135
Total other income (expense)	-1,185,366	2,946,224	-1,717,317	1,374,842
Net income (loss) from operations before provision for income taxes	-2,430,583	1,405,313	-6,984,301	-1,806,743
Provision for income taxes	'	-4,540	'	-9,031
Net income (loss)	($2,430,583)	$1,400,773	($6,984,301)	($1,815,774)
Net income (loss) per share, basic and diluted	($0.08)	$0.17	($0.25)	($0.22)
Weighted average number of common shares outstanding, basic and diluted	29,902,061	8,236,980	27,911,904	8,181,054

CONDENSED_STATEMENT_OF_CASH_FL

CONDENSED STATEMENT OF CASH FLOWS (USD $)	6 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities	'	'
Net loss	($6,984,301)	($1,815,774)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Depreciation and amortization	29,592	3,362
Amortization of discounts on note payable	1,685,563	3,045,414
Amortization of debt offering costs	'	366,528
Impairment of Union Pacific deposit	'	600,000
Deferred tax provision	'	9,031
Change in value of derivative liability	-419,602	-4,910,135
Stock issued for services	594,090	188,731
Stock option compensation	2,671,898	'
Warrants issued for services	164,708	'
Loss on settlement on accounts payable for stock	223,830	386,498
Changes in operating assets and liabilities:	'	'
Change in Accounts receivable	-72,599	'
Change in Other current assets	19,950	145,003
Change in Other assets	885	3,098
Liabilities of discontinued operations, net	'	-111,000
Accounts payable and accrued expenses	296,131	99,668
Net cash used in operating activities	-1,789,855	-1,989,576
Cash flows from investing activities	'	'
Purchases of property and equipment	-39,546	-105,565
Net cash used in investing activities	-39,546	-105,565
Cash flows from financing activities	'	'
Proceeds from sale on shares of common stock	405,300	'
Proceeds from exercise of stock options	1,087	'
Proceeds from convertible notes payable	1,280,679	880,000
Proceeds from notes payable - related parties	59,000	'
Net cash provided by financing activities	1,746,066	880,000
Net change in cash	-83,335	-1,215,141
Cash, beginning of the period	87,910	1,262,615
Cash, end of the period	4,575	47,474
Supplemental disclosure of cash flow information:	'	'
Interest paid	'	'
Income taxes paid	'	'
Supplemental disclosure of non-cash investing and financing transactions:	'	'
Stock issued as payment of accounts payable	120,442	'
Stock issued for debt and accrued interest	$135,132	$374,933

1_Organization_and_Basis_of_Pr

(1) Organization and Basis of Presentation	6 Months Ended
	Sep. 30, 2014
Notes	'
(1) Organization and Basis of Presentation	'
	(1)           Organization and basis of presentation
	Basis of Financial Statement Presentation:
	The accompanying unaudited interim financial statements of Las Vegas Railway Express, Inc. (the "Company") have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all information and footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete financial statements. These statements reflect all normal and recurring adjustments which, in the opinion of management, are necessary to present fairly the financial position, results of operations and cash flows of the Company for the interim periods presented. However, the results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the year ending March 31, 2015 or any other future period. These interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2014.
	Going Concern:
	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements, the Company has net losses of $6,984,301 for the six months ended September 30, 2014.  The Company also has an accumulated deficit of $38,611,947, and a negative working capital of $5,168,558 as of September 30, 2014, as well as outstanding convertible notes payable of $3,168,547.  Management believes that it will need additional equity or debt financing to be able to implement its business plan.  Given the lack of revenue, capital deficiency and negative working capital, there is substantial doubt about the Company’s ability to continue as a going concern.
	Management is attempting to raise additional equity and debt to sustain operations until it can market its services and achieves profitability.  The successful outcome of future activities cannot be determined at this time and there are no assurances that, if achieved, the Company will have sufficient funds to execute its intended business plan or generate positive operating results.
	The accompanying financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

2_Summary_of_Significant_Accou

(2) Summary of Significant Accounting Policies	6 Months Ended
	Sep. 30, 2014
Notes	'
(2) Summary of Significant Accounting Policies	'
	(2)           Summary of Significant Accounting Policies
	Risks and Uncertainties:
	The Company operates in an industry that is subject to intense competition and potential government regulations.  Significant changes in regulations and the inability of the Company to establish contracts with rail services providers could have a materially adverse impact on the Company’s operations.
	Use of Estimates:
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reported periods.
	Property and Equipment:
	Property and equipment are recorded at historical cost and depreciated on a straight-line basis over their estimated useful lives of approximately five years once the individual assets are placed in service.  The Company expenses all purchases of equipment with individual costs of under $500, and these amounts are not material to the financial statements.
	Long-Lived Assets:
	In accordance with FASB ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. Impairment, if any, is based on the excess of the carrying amount over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made.  The Company’s management believes there has been no impairment of its long-lived assets during the six months ended September 30, 2014, or 2013.  There can be no assurance, however, that market conditions will not change or demand for the Company’s business model will continue.  Either of these could result in future impairment of long-lived assets.
	Income Taxes:
	Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The deferred tax assets of the Company relate primarily to operating loss carryforwards for federal income tax purposes. A full valuation allowance for deferred tax assets has been provided because the Company believes it is not more likely than not that the deferred tax asset will be realized. Realization of deferred tax assets is dependent on the Company generating sufficient taxable income in future periods.
	The Company periodically evaluates its tax positions to determine whether it is more likely than not that such positions would be sustained upon examination by a tax authority for all open tax years, as defined by the statute of limitations, based on their technical merits.  As of September 30, 2014, and March 31, 2014, the Company has not established a liability for uncertain tax positions.
	Basic and Diluted Loss per Share:
	In accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 260, “Earnings per Share,” the basic income (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average common shares outstanding during the period.  Diluted earnings per share reflect per share amounts that would have resulted if diluted potential common stock had been converted to common stock.  Common stock equivalents have not been included in the earnings per share computation for the three and six months ended September 30, 2014, and 2013 as the amounts are anti-dilutive.  As of September 30, 2014, the Company had 2,266,073 outstanding stock options, convertible debt of $3,168,547, before debt discount of $381,815 and 9,070,650 of outstanding warrants, which were all excluded from the computation as they were anti-dilutive.
	Share Based Payment:
	The Company issues stock, options, and warrants as share-based compensation to employees and non-employees.
	The Company accounts for its share-based compensation to employees in accordance FASB ASC 718.  Stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense over the requisite service period.
	The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505-50 “Equity - Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The final fair value of the share-based payment transaction is determined at the performance completion date. For interim periods, the fair value is estimated and the percentage of completion is applied to that estimate to determine the cumulative expense recorded.
	The Company values stock compensation based on the market price on the measurement date. As described above, for employees this is the date of grant, and for non-employees, this is the date of performance completion.
	The Company values stock options and warrants that do not qualify as derivative instruments using the Black-Scholes option pricing model.  Assumptions used in the Black-Scholes model to value options and warrants issued during the six months ended September 30, 2014 were as follows.  There were no options or warrants granted during the six months ended September 30, 2013 that were valued using the Black-Scholes model.
				Six Months Ended		Six Months Ended
				September 30,		September 30,
				2014		2013
	Expected life in years			2.5		NA
	Stock price volatility			170.94% - 214.60%		NA
	Risk free interest rate			0.76% - 1.10%		NA
	Expected dividends			NA		NA
	Forfeiture rate			0%		NA
	Derivative Liabilities:
	In connection with the private placement of convertible notes beginning in February 2013, the Company became contingently obligated to issue shares of common stock in excess of our then maximum of 200 million shares of authorized common stock under the Company’s certificate of incorporation.  Consequently, the ability to settle these obligations with shares would be unavailable causing these obligations to potentially be settled in cash. This condition created a derivative liability.
	The Company has a sequencing policy regarding share settlement wherein instruments with the earliest issuance date would be settled first. The sequencing policy also considers contingently issuable additional shares, such as those issuable upon a stock split, to have an issuance date to coincide with the event giving rise to the additional shares.
	On December 2, 2013, the Company effected a one-for-twenty reverse stock split of the Company’s issued and outstanding common stock shares.  As a result, the Company’s outstanding shares of common stock and common stock equivalents no longer exceeded the number of authorized shares.  As a result, as of December 2, 2013, these instruments that were accounted for as derivative liabilities were reclassified as equity.
	The Company also has certain warrants and embedded conversion options in notes payable with elements that qualify as derivatives. The warrants have anti-dilution clauses that prevent calculation of the ultimate number of shares that may be issued upon exercise, and four outstanding notes payable that had a variable conversion feature that similarly prevented the calculation of the number of shares into which they were convertible.
	The Company values these warrants and embedded conversion options in notes payable using the Black-Scholes model.  The resulting liability is valued at each reporting date and the change in the liability is reflected as change in derivative liability in the condensed statement of operations.
	In determining the appropriate fair value of the derivative liabilities, the Company used the following input levels for its valuation methodology (see Note 6 for more information regarding the Company’s derivative instruments).
			Fair Value			Fair Value Measurements at September 30, 2014
			as of			Using Fair Value Hierarchy
			30-Sep-14			Level 1		Level 2		Level 3
	Liabilities:
	Derivative liability	$	2,013,742		$	-	$	2,013,742	$	-
	New Accounting Pronouncements:
	There are no new significant accounting standards applicable to the Company that have been issued but not yet adopted by the Company as of September 30, 2014, and through the date of this filing.

3_Property_and_Equipment

(3) Property and Equipment	6 Months Ended
	Sep. 30, 2014
Notes	'
(3) Property and Equipment	'
	(3)            Property and Equipment
	Property and equipment consisted of the following.
			September 30,		March 31,
			2014		2014
			(Unaudited)
	Office equipment	$	65,548	$	61,611
	Computer software		24,166		24,167
	Transportation equipment under construction		657,412		621,802
			747,126		707,580
	Less: accumulated depreciation		(52,765)		(23,173)
		$	694,361	$	684,407

4_Short_Term_Notes_Payable

(4) Short Term Notes Payable	6 Months Ended
	Sep. 30, 2014
Notes	'
(4) Short Term Notes Payable	'
	(4)           Short Term Notes Payable
	A summary of outstanding notes payable is as follows:
	Secured promissory notes, dated May 17, 2011 through
	May 17, 2012 to an investor bearing interest at 8% per annum,
	payable on May 17, 2012.	$	-	$		13,333
	Total outstanding notes payable	$	-		$	13,333
	The above note payable was repaid in full during the six months ended September 30, 2014 in connection with the Debt Securities Assignment and Purchase agreement (see Note 7 for more information regarding the Company’s equity).

5_Convertible_Notes_Payable

(5) Convertible Notes Payable	6 Months Ended
	Sep. 30, 2014
Notes	'
(5) Convertible Notes Payable	'
	(5)           Convertible Notes Payable
	On October 1, 2013, the Company entered into a promissory note with JMJ Financial which provides for the Company to borrow up to $350,000 in principal (the “JMJ Note”).  As of March 31, 2014, the Company had borrowed $150,000 under this Promissory Note.  Outstanding borrowings mature two years from the effective date of each advance.  If the outstanding balance of the note is repaid by the Company on or before 90 days from the effective date of the borrowing, the interest charged is 0%.  However, if the Company does not repay the note within 90 days, a one-time interest charge of 12% shall be applied to the outstanding principal sum.  The outstanding balance of the note may be converted into common stock at the option of the debt holder at a rate equal to the lower of $0.90 per share, or 60% of the lowest trading price in the 25 days trading days previous to the conversion date, subject to other adjustments in the agreement.  During the three months ended June 30, 2014, the Company borrowed an additional $40,000 under the JMJ Note.  During the three months ended June 30, 2014, JMJ Financial converted $69,785 of outstanding principal into 785,000 shares of common stock under the terms of the agreement.  During the three months ended September 30, 2014, JMJ Financial converted an additional $39,490 of outstanding principal into 3,800,000 shares of common stock. As of September 30, 2014, the outstanding balance of the JMJ Note amounted to $80,635.
	On November 22, 2013, the Company, entered into and closed a purchase agreement (the “Purchase Agreement”) with an institutional investor, pursuant to which the Company sold to the investor a senior secured convertible promissory note in the principal amount of $1,750,000 (the “Note”), and warrants to purchase 300,000 shares of common stock (the “Warrants”), for an aggregate purchase price of $1,750,000. The Note was scheduled to mature on June 30, 2014, bears interest at the rate of 10% per year payable on maturity in cash or shares of common stock at the Company’s option (subject to certain conditions), and is convertible into shares of the Company’s common stock at a conversion price equal to $0.70, subject to adjustment in the event of future stock splits, stock dividends, and similar transactions, or in the event of subsequent equity sales by the Company at a price lower than the conversion price then in effect.  The Company’s obligations under the Note are secured by substantially all of the Company’s assets.  The Warrants have a five year term, are exercisable on a cash or cashless basis, and have an exercise price equal to $1.00, subject to adjustment in the event of future stock splits, stock dividends, and similar transactions, or in the event of subsequent equity sales by the Company at a price lower than the exercise price then in effect.
	On March 24, 2014, the Company entered into a Convertible Promissory Note with Iconic Holdings, LLC (the “Iconic Note”) in which the Company has access to borrow a total principal amount of $165,000.  All borrowings incur interest at a rate of 8% per annum, which is payable as of the maturity date of March 24, 2015.  The initial borrowing made by the Company amounted to $55,000, which represented the amount outstanding on the Iconic Note as of March 31, 2014.  At the option of the debt holder, the outstanding balance may be converted at any time into shares of the Company’s common stock at a conversion rate equal to the lower of $0.50 or 60% of the lowest trading price of the Company’s common stock during the 25 consecutive trading days prior to conversion election date.  During the three months ended June 30, 2014, the Company borrowed an additional $100,000 under the Iconic Note.  The outstanding principal balance as of September 30, 2014 amounted to $155,000.
	On March 25, 2014, the Company entered into a convertible note agreement with KBM Worldwide, Inc. (the “KBM Note”) for total principal borrowings of $68,000.  The amounts are due nine months after the issuance of the note on December 25, 2014, and bear interest at a rate of 8% per annum.  At the option of the debt holder, beginning 180 days after the issuance of the note, the debt holder may convert the outstanding balance of the KBM Note into shares of the Company’s common stock at a conversion rate equal to 61% of the average of the lowest three closing trading prices during the 10 trading day period prior to the conversion election date.  During the three months ended September 30, 2014, KBM Worldwide, Inc. converted $10,000 of outstanding principal into 877,193 shares of common stock under the terms of the agreement.  As of September 30, 2014, the note had an outstanding principal balance of $58,000.
	On April 2, 2014, the Company entered into a convertible promissory note for $100,000 with Beaufort Capital Partners LLC with a maturity date of October 2, 2014.  The note is convertible into shares of the Company’s common stock at a discount of 42% of the lowest traded price during the 5 trading days preceding the conversion date.
	On April 11, 2014, the Company entered into a Note Exchange Agreement with the debt holder holding the $1,750,000 senior secured convertible promissory note originally issued on November 22, 2013 under the Purchase Agreement.  Under the terms of the Note Exchange Agreement, the original senior secured convertible promissory note is cancelled and replaced with a new note for $2,000,000.  The new note matures on November 30, 2014, bears interest at the rate of 10% per year payable on maturity in cash or shares of common stock at the Company’s option (subject to certain conditions), and is convertible into shares of the Company’s common stock at a conversion price equal to $0.45, subject to adjustments in the event of future stock splits, stock dividends, and similar transactions, or in the event of subsequent equity sales by the Company at a price lower than the conversion price then in effect.  Under the new note, the Company’s obligations are secured by substantially all of the Company’s assets, excluding any railcar assets.
	The difference between the book value of the principal and accrued interest of the old note of $1,818,055 and the value of the new note of $2,000,000 of $181,944 was recorded as interest expense during the three months ended June 30, 2014.  As of September 30, 2014, the note had an outstanding principal balance of $2,000,000.
	On April 17, 2014, the Company entered into a convertible note payable with Vista Capital Investments, LLC providing for borrowings up to $250,000 with a maturity date of April 17, 2016.  The note has a one-time interest charge of 12% and is due on the maturity date. The outstanding balance of the note along with accrued interest is convertible into shares of the Company’s common stock at a rate equal to the lesser of $0.25 or 60% of the lowest trade occurring during the 25 trading days preceding the conversion date.  The Company received borrowings under this convertible note payable of $50,000 in April 2014, which represented the outstanding balance as of September 30, 2014.
	On April 30, 2014, the Company entered into a convertible note payable with Redwood Management, LLC providing for total borrowings of $250,000, which is payable in 3 installments of $83,333, the first due installment upon execution of the note, the second installment due one month after execution, and the final installment due two months after execution.  Interest on the note equals 10% of the total principal balance, regardless of how long the note is outstanding for.  The Company received payments of $166,667 during the three months ended June 30, 2014, and the final $83,333 during the three months ended September 30, 2014.  The convertible note matures 6 months after the issuance, at which point the outstanding principal and interest is due.  The outstanding balance related to this note amounted to $250,000 as of September, 2014.
	On May 6, 2014, the Company entered into a convertible note payable with KBM Worldwide, Inc. providing for total borrowings of $32,500 which accrue interest at a rate of 8% per annum.  The convertible note matures and is due in full on February 12, 2015 along with any unpaid accrued interest.  The outstanding principal and accrued interest is convertible into shares of common stock at the option of the holder at a conversion rate equal to 61% of the average of the lowest 3 trading prices during the 10 trading days prior to the conversion.
	On May 12, 2014, the Company entered into a secured convertible promissory note with Typenex Co-Investment, LLC (the “Typenex Note”) providing for total borrowings up to $335,000 which accrue interest at a rate of 10% per annum.  All outstanding borrowings mature and are due in 20 months from the issuance date.  The Company received an initial payment of $87,500 on the note issuance date.  The outstanding principal and interest is convertible into shares of common stock at the option of the holder at a conversion rate equal to the lesser of $0.35 per share or 60% of the average of the 3 lowest closing bid prices in the 20 trading days preceding the conversion date.  If the average of the 3 lowest closing bid prices is less than $0.10, then the conversion factor is reduced from 60% to 55%.  The debt holder was also issued warrants on May 12, 2014 in connection with this note payable granting the right to purchase a number of common stock shares equal to $167,500 divided by the market price (defined as the higher of the closing price on the issuance date or the volume weighted average price of the stock for the trading day that is 2 days prior to the exercise date) at an exercise price of $0.35 per share.  The outstanding balance related to this note amounted to $87,500 as of September 30, 2014.
	On May 28, 2014, the Company entered into a convertible promissory note with Beaufort Capital Partners LLC providing for borrowings of $125,000.  The convertible promissory note matures on August 28, 2014, at which point the Company owes $187,500 which includes a total of $62,500 in interest expense.  The outstanding amounts are convertible into shares of common stock at the option of the holder at a conversion rate equal to 60% of the lowest traded price during the prior 20 trading days from the date of the conversion.
	On June 13, 2014, the Company entered a convertible debenture agreement with Group 10 Holdings, LLC providing for total borrowing of $55,000 which accrue interest at the rate of 12% per annum. All borrowings mature and are due in one year from the issuance date. The debenture is convertible into shares of common stock at the option of the holder at the conversion rate lesser of 55% discount of the lowest closing bid price during the 25 trading days prior to the date of notice conversion or $0.25 per share.  In connection with the agreement, the Company issued 50,000 shares of common stock as a commitment fee.  The fair value of the common stock issued amounted to $8,500 and has been recorded as a discount to the note payable.  The amount is being amortized into interest expense through the maturity date of June 13, 2015.
	On July 1, 2014, the Company entered into a convertible promissory note with KBM Worldwide, Inc. for borrowings of $32,500 which bear interest at a rate of 8% per annum.  The outstanding borrowings and accrued interest are payable on March 19, 2015.  The outstanding amounts are convertible into shares of common stock at the debt holder’s option at a conversion rate equal to 61% of the average of the lowest three trading prices during the 10 trading days prior to the conversion.
	On July 18, 2014, the Company entered into a convertible note payable with LG Capital Funding, LLC providing for total borrowings of $90,000, which is payable in 2 installments of $45,000.  Interest on the note equals 8% of the total principal balance. The Company received payment of $45,000 on July 22, 2014, which represents the total amounts outstanding as of September 30, 2014.  The convertible note matures 12 months after the issuance, at which point the outstanding principal and interest is due.  The outstanding amounts are convertible into shares of common stock at a conversion rate equal to 57% of the lowest trading price during the fifteen trading days prior to the conversion.
	On July 24, 2014, the Company entered into a security purchase agreement with ADAR Bays, LLC providing for total borrowings of $71,000, with the first note being of $36,000 and the second note being in the amount of $35,000.  Interest on the note equals 8% of the total principal balance. The Company received payment of $36,000 on July 28, 2014, which represents the total amount outstanding as of September 30, 2014.  The convertible note matures 12 months after the issuance, at which point the outstanding principal and interest is due.  The outstanding amounts are convertible into shares of common stock at a conversion rate equal to 57% of the lowest trading price during the fifteen trading days prior to the conversion.
	On August 15, 2014, the Company entered into a convertible promissory note with KBM Worldwide, Inc. providing for total borrowings of $32,500 which bears interest at a rate of 8% per annum.  The convertible note matures on May 15, 2015, at which point the outstanding principal and interest is due.  The outstanding amounts are convertible into shares of common stock at a conversion rate equal to 61% of the average of the 3 lowest trading price during the ten trading days prior to the conversion.
	On September 23, 2014, the Company entered into a convertible promissory note with JSJ Investments, Inc. providing for total borrowings of $44,679 which bears interest at a rate of 15% per annum.  The convertible note matures on March 23, 2015, at which point the outstanding principal and interest is due.  The outstanding amounts are convertible into shares of common stock at a conversion rate equal to 61% of the average of the 3 lowest trading price during the ten trading days prior to the conversion.  During the three months ended September 30, 2014, JSJ Investments, Inc. converted $15,767 of outstanding principal into 2,810,504 shares of common stock under the terms of the agreement.  As of September 30, 2014, the note had an outstanding principal balance of $28,912.
	The above warrants issued with respect to the Purchase Agreement and Typenex Note described above have anti-dilution clauses and variable exercise rates that prevent calculation of the ultimate number of shares that may be issued upon exercise, and all of the outstanding convertible note balances described above have variable conversion features that similarly prevented the calculation of the number of shares into which they were convertible.  As a result, the Company accounts for both the conversion feature associated with these notes and the warrants as derivatives.  The Company values these warrants and conversion features using the Black-Scholes method.  The resulting liability is valued at each reporting date and the change in the liability is reflected as change in derivative liability in the statement of operations.
	The following summarizes the book value of the convertible notes payable outstanding as of September 30, 2014 and March 31, 2014:
			September 30,		March 31,
			2014		2014
			(Unaudited)
	Principal balance of convertible notes payable outstanding	$	3,168,547	$	2,023,000
	Less: discount on convertible notes payable		(381,815)		(601,016)
	Convertible notes payable, net	$	2,786,732	$	1,421,984
	Future scheduled maturities of these notes payable are as follows:
			Year Ended
			September 30,
	2015	$	2,950,412
	2016		218,135
	Total	$	3,168,547
	Fair Value of Financial Instruments:
	The Company's financial instruments as defined by FASB ASC 825-10-50 include cash, notes payable and derivative liabilities.  Derivative liabilities are recorded at fair value.  The principal balance of notes payable approximates fair value because current interest rates and terms offered to the Company for similar debt are substantially the same.
	FASB ASC 820 defines fair value, establishes a framework for measuring fair value, in accordance with generally accepted accounting principles, and expands disclosures about fair value measurements. FASB ASC 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows:
	Level 1. Observable inputs such as quoted prices in active markets;
	Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
	Level 3. Unobservable inputs in which there is little or no market data, which requires the reporting entity to develop its own assumptions.

6_Derivative_Instruments

(6) Derivative Instruments	6 Months Ended
	Sep. 30, 2014
Notes	'
(6) Derivative Instruments	'
	(6)           Derivative Instruments
	Excess Shares
	In connection with the private placement of convertible notes beginning in February 2013, the Company became contingently obligated to issue shares of common stock in excess of our then maximum of 200 million shares of authorized common stock under the Company’s certificate of incorporation.  Consequently, the ability to settle these obligations with shares would be unavailable causing these obligations to potentially be settled in cash. This condition creates a derivative liability.
	The Company had a sequencing policy regarding share settlement wherein instruments with the earliest issuance date would be settled first. The sequencing policy also considers contingently issuable additional shares, such as those issuable upon a stock split or anti-dilution, to have an issuance date to coincide with the event giving rise to the additional shares.
	Using this sequencing policy, all instruments convertible into common stock, including warrants and the conversion feature of notes payable, issued subsequent to November 30, 2012 were classified as derivative liabilities. On December 2, 2013, the Company effected a one-for-twenty reverse stock split of the Company’s issued and outstanding common stock shares.  As a result, the Company’s outstanding shares of common stock and common stock equivalents no longer exceeded the number of authorized shares.  As a result, as of December 2, 2013, these instruments that were accounted for as derivative liabilities were reclassified as equity.
	Other Derivatives
	The Company has certain warrants and convertible notes payable with elements that qualify as derivatives. The warrants have anti-dilution clauses that prevent calculation of the ultimate number of shares that may be issued upon exercise, and the convertible notes payables have variable conversion features that similarly prevented the calculation of the number of shares into which they were convertible.
	The September 30, 2014 derivative liability was valued using the Black-Scholes model, the September 30, 2013 derivative liability was valued the binomial lattice method, with the following inputs used for each respective period.
		Warrants	Notes Payable	Notes Payable& Warrants
		Six Months Ended	Six Months Ended	Six Months Ended
		September 30, 2014	September 30, 2014	September 30, 2013
	Expected life in years	2.9	0.7	0.38 – 9.41 years
	Stock price volatility	193.7% - 272.7%	204.9% - 550.5%	112.3% - 273.7%
	Discount rate	0.13% - 1.78%	0.03% - 0.13%	0.03% - 2.47%
	Expected dividends	None	None	None
	Forfeiture rate	0%	0%	0%

7_Equity

(7) Equity	6 Months Ended
	Sep. 30, 2014
Notes	'
(7) Equity	'
	(7)             Equity
	Common Stock
	The Company is authorized to issue 500,000,000 shares of common stock and no other class of stock at this time.  The increase in authorized shares from 200,000,000 to 500,000,000 was approved by the shareholders and Board of Directors at the annual meeting held at the Company’s corporate office on September 30, 2014. The holders of common stock are entitled to one vote per share on all matters submitted to a vote of stockholders and are not entitled to cumulate their votes in the election of directors.  The holders of common stock are entitled to any dividends that may be declared by the Board of Directors out of funds legally available therefore subject to the prior rights of holders of any outstanding shares of preferred stock and any contractual restrictions we have against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock.  Holders of common stock have no preemptive or other subscription rights and no right to convert their common stock into any other securities.
	During the six months ended September 30, 2013, the Company issued an aggregate of 374,910 shares of common stock for the conversion of $374,933 in convertible notes payable and accrued interest.  This included 200,000 shares of common stock for the conversion of a $200,000 convertible note payable held by a related party entity owned by a Director of the Company.  During the six months ended September 30, 2014 the Company issued an aggregate of 8,272,697 of common stock for the conversion of $135,132 of outstanding notes payable.
	During the six months ended September 30, 2013, the Company issued an aggregate of 432,000 shares of common stock as payment for services, directors’ and employee compensation resulting in total expense of $188,731.  During the six months ended September 30, 2014, the Company issued an aggregate of 12,050,718 shares of common stock as payment for services, directors’ and employee compensation resulting in an expense of $2,671,898.  The fair value of the directors’ and employees’ service was determined by the closing price of the stock on date of grant and board of director minutes authorizing the shares. Out of the expense of $2,671,898 approximately $660,000 was direct payroll expense.
	During the six months ended September 30, 2013, the Company issued 9,823 shares of common stock for the exercise of warrants.  There were no warrants exercised during the six months ended September 30, 2014.
	During the six months ended September 30, 2014, the Company issued 11,950,718 shares of common stock for the exercise of stock options.  There were no stock options exercised during the six months ended September 30, 2013.
	On May 30, 2014, the Company entered into a Debt Securities Assignment and Purchase agreement, along with a Securities Exchange and Settlement Agreement with Beaufort Capital Partners LLC (“Beaufort”).  Per the terms of the agreements, the Company assigned $105,256 of outstanding accounts payable to Beaufort, in exchange for allowing Beaufort to convert the amounts into common stock, at a date of their choosing, at a rate equal to 40% of the lowest traded price over the 20 days previous to the conversion date.  During the six months ended September 30, 2014, Beaufort elected to convert $85,443 into 5,261,615 shares of common stock per the terms of the agreement.  The difference between the conversion amount of $85,443 and the fair value of the shares issued amounted to $229,923, and was recorded as interest expense during the six months ended September 30, 2014.
	On August 8, 2014, the Company entered into Debt Securities Assignment with Macallan Partners LLC (“Macallan”) which provide for the assignment of $20,000 of liabilities from the Company to Macallan in exchange for allowing Macallan to convert the amount into 1,300,000 shares of common stock at the set price of $0.0154. The difference between the conversion amount of $20,000 and the fair value of the shares issued amounted to $45,000, and was recorded as interest expense during the six months ended September 30, 2014.
	On September 12, 2014, the Company entered into Debt Securities Assignment with Macallan Partners LLC (“Macallan”) which provide for the assignment of $15,000 of liabilities from the Company to Macallan in exchange for allowing Macallan to convert the amount into 2,000,000 shares of common stock at the set price of $0.0075. The difference between the conversion amount of $15,000 and the fair value of the shares issued amounted to $51,000, and was recorded as interest expense during the six months ended September 30, 2014.
	As of September 30, 2014, the amount of $19,813 is still outstanding as Beaufort has not elected to convert the amount yet and the amount of $14,772 is still outstanding as Macallan has not elected to convert the amount yet. As the amounts are required to be paid in common stock, the Company has classified these amounts as “Common Stock Payable”, a component of stockholders equity on the accompanying condensed balance sheet as of September 30, 2014.
	Warrants
	During the six months ended September 30, 2013, the Company issued an aggregate of 880,000 warrants in connection with the convertible notes issued during the period, as well as 238,000 warrants for the payment of commissions associated with acquiring the convertible notes.  These warrants have been accounted for as derivative liabilities (see Note 6).
	During the six months ended September 30, 2013, the Company issued an additional 100,000 warrants as payment of directors’ services.  The warrants have been accounted for as derivative liabilities (see Note 6 for more information regarding the Company’s derivative instruments).
	During the six months ended September 30, 2014, the Company issued warrants in connection with the Typenex Note (see Note 5) granting the debt holder the right to purchase a number of common stock shares equal to $167,500 divided by the market price (defined as the higher of the closing price on the issuance date or the volume weighted average price of the stock for the trading day that is 2 days prior to the exercise date) at an exercise price of $0.35 per share.  The warrants have been accounted for as derivative liabilities (see Note 6 for more information regarding the Company’s derivative instruments).
	During the six months ended September 30, 2014, the Company issued warrants in connection with stock purchase agreements granting the debt holders the right to purchase 6,755,001 common stock shares equal at the exercise price of $0.01 per share.
	Warrant	Number of shares	Life outstanding	Exercise price
	602	1,666,667	3 years	0.001
	603	833,334	3 years	0.001
	604	1,666,667	3 years	0.001
	605	166,667	3 years	0.001
	606	416,667	3 years	0.001
	607	1,666,667	3 years	0.001
	608	250,000	3 years	0.001
	609	63,333	3 years	0.001
	610	25,000	3 years	0.001
	Total	6,755,001

8_Stock_Option_Plan

(8) Stock Option Plan	6 Months Ended
	Sep. 30, 2014
Notes	'
(8) Stock Option Plan:	'
	(8)             Stock Option Plan:
	The Company’s 2011 Stock Option Plan provides for the grant of 1,000,000 incentive or non-statutory stock options to purchase common stock. Employees, who share the responsibility for the management growth or protection of the business of the Company and certain non-employees, are eligible to receive options which are approved by a committee of the Board of Directors.  These options vest over five years and are exercisable for a ten-year period from the date of the grant.  As of September 30, 2014 and March 31, 2014, the Company had 100,000 fully vested options outstanding under the 2011 Stock Option Plan at an exercise price of $10.00 per share.  The options expire in November 2018.
	On April 1, 2014, the Company adopted the 2014 Stock Option Plan which provides for the grant of options to certain members of management totaling an aggregate of 20% of the total issued and outstanding shares of common stock.  The options are considered granted on each day that the Company issues shares, at which point the Company values the options using the Black-Scholes method and records the applicable share-based compensation expense.   On April 1, 2014, the Company also issued stock options to directors as compensation which provides for the purchase of an aggregate total of 2,000,000 shares of common stock.  All options granted have an exercise price of $0.0001 per share.  The stock options are fully vested on the date of issuance and have a contractual life of 5 years.
	The following is a summary of the Company’s stock option activity:
							Weighted-
					Weighted-		Average
					Average		Remaining		Aggregate
					Exercise		Contractual		Intrinsic
		Options			Price		Life (Years)		Value
	Outstanding at March 31, 2014	100,000		$	10.00		4.59	$	-
	Granted	14,116,791			0.0001				2,671,613
	Exercised	(11,950,718)			0.0001				1,472,431
	Outstanding at September 30, 2014 (unaudited)	2,266,073		$	0.44		4.77	$	21,444
	Vested at September 30, 2014	2,266,073		$	0.44		4.77	$	21,444
	Exercisable at September 30, 2014	2,266,073		$	0.44		4.77	$	21,444
	As of September 30, 2014, the Company had no unvested stock options or unrecognized stock option expense.  The weighted average grant date fair value of options granted during the six months ended September 30, 2014 amounted to $0.19 per option.
	The following table summarizes information about stock options outstanding and exercisable at September 30, 2014.
	Options Outstanding and Exercisable
			Weighted			Weighted
			Average			Average
	Number		Remaining			Exercise
	of Shares		Life (Years)			Price
	100,000		4.09		$	10.00
	2,166,073		4.8		$	0.0001
	2,266,073		4.77		$	0.44

9_Related_Party_Transactions_D

(9) Related Party Transactions Disclosure	6 Months Ended
	Sep. 30, 2014
Notes	'
(9) Related Party Transactions Disclosure	'
	(9)          Related Party Transactions
	During the six months ended September 30, 2014, the Company entered into short-term borrowings with the Chief Financial Officer, Eclipse Holding and Allegheny Nevada Holdings Corporation amounting to a total of $59,000.  The outstanding amounts accrue interest at a rate of 10% per month and are payable on demand.

10_Subsequent_Events

(10) Subsequent Events	6 Months Ended
	Sep. 30, 2014
Notes	'
(10) Subsequent Events	'
	(10)          Subsequent Events
	During the month of October and November 2014 the Company issued 124,342,997 shares of Company’s common stock for promissory note conversions of $150,833.
	During the month of October 2014 the Company issued 2,091,837 shares of Company’s common stock for debt conversion of $4,100.
	During the month of November 2014 the Company issued 30,000,000 shares of common stock to the investors for $60,000 cash investment.
	On November 7, 2014 the Company issued 19,804,176 shares of Company’s common stock for compensation.
	On November 10, 2014 the Company issued 2,700,000 shares of Company’s common stock for services, 4,416,668 shares of common stock for exercise of warrants and 1,500,000 shares for compensation.
	The Company has evaluated subsequent events from September 30, 2014 through the date the financial statements were available to be issued and has determined that, other than as disclosed above, there are no items to disclose.

2_Summary_of_Significant_Accou1

(2) Summary of Significant Accounting Policies: Risks and Uncertainties (Policies)	6 Months Ended
	Sep. 30, 2014
Policies	'
Risks and Uncertainties:	'
	Risks and Uncertainties:
	The Company operates in an industry that is subject to intense competition and potential government regulations.  Significant changes in regulations and the inability of the Company to establish contracts with rail services providers could have a materially adverse impact on the Company’s operations.

2_Summary_of_Significant_Accou2

(2) Summary of Significant Accounting Policies: Use of Estimates (Policies)	6 Months Ended
	Sep. 30, 2014
Policies	'
Use of Estimates:	'
	Use of Estimates:
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reported periods.

2_Summary_of_Significant_Accou3

(2) Summary of Significant Accounting Policies: Property and Equipment (Policies)	6 Months Ended
	Sep. 30, 2014
Policies	'
Property and Equipment:	'
	Property and Equipment:
	Property and equipment are recorded at historical cost and depreciated on a straight-line basis over their estimated useful lives of approximately five years once the individual assets are placed in service.  The Company expenses all purchases of equipment with individual costs of under $500, and these amounts are not material to the financial statements.

2_Summary_of_Significant_Accou4

(2) Summary of Significant Accounting Policies: Long-Lived Assets Policy (Policies)	6 Months Ended
	Sep. 30, 2014
Policies	'
Long-Lived Assets Policy	'
	Long-Lived Assets:
	In accordance with FASB ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. Impairment, if any, is based on the excess of the carrying amount over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made.  The Company’s management believes there has been no impairment of its long-lived assets during the six months ended September 30, 2014, or 2013.  There can be no assurance, however, that market conditions will not change or demand for the Company’s business model will continue.  Either of these could result in future impairment of long-lived assets.

2_Summary_of_Significant_Accou5

(2) Summary of Significant Accounting Policies: Income Taxes (Policies)	6 Months Ended
	Sep. 30, 2014
Policies	'
Income Taxes	'
	Income Taxes:
	Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The deferred tax assets of the Company relate primarily to operating loss carryforwards for federal income tax purposes. A full valuation allowance for deferred tax assets has been provided because the Company believes it is not more likely than not that the deferred tax asset will be realized. Realization of deferred tax assets is dependent on the Company generating sufficient taxable income in future periods.
	The Company periodically evaluates its tax positions to determine whether it is more likely than not that such positions would be sustained upon examination by a tax authority for all open tax years, as defined by the statute of limitations, based on their technical merits.  As of September 30, 2014, and March 31, 2014, the Company has not established a liability for uncertain tax positions.

2_Summary_of_Significant_Accou6

(2) Summary of Significant Accounting Policies: Basic and Diluted Loss Per Share (Policies)	6 Months Ended
	Sep. 30, 2014
Policies	'
Basic and Diluted Loss Per Share:	'
	Basic and Diluted Loss per Share:
	In accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 260, “Earnings per Share,” the basic income (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average common shares outstanding during the period.  Diluted earnings per share reflect per share amounts that would have resulted if diluted potential common stock had been converted to common stock.  Common stock equivalents have not been included in the earnings per share computation for the three and six months ended September 30, 2014, and 2013 as the amounts are anti-dilutive.  As of September 30, 2014, the Company had 2,266,073 outstanding stock options, convertible debt of $3,168,547, before debt discount of $381,815 and 9,070,650 of outstanding warrants, which were all excluded from the computation as they were anti-dilutive.

2_Summary_of_Significant_Accou7

(2) Summary of Significant Accounting Policies: Share Based Payment (Policies)	6 Months Ended
	Sep. 30, 2014
Policies	'
Share Based Payment	'
	Share Based Payment:
	The Company issues stock, options, and warrants as share-based compensation to employees and non-employees.
	The Company accounts for its share-based compensation to employees in accordance FASB ASC 718.  Stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense over the requisite service period.
	The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505-50 “Equity - Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The final fair value of the share-based payment transaction is determined at the performance completion date. For interim periods, the fair value is estimated and the percentage of completion is applied to that estimate to determine the cumulative expense recorded.
	The Company values stock compensation based on the market price on the measurement date. As described above, for employees this is the date of grant, and for non-employees, this is the date of performance completion.
	The Company values stock options and warrants that do not qualify as derivative instruments using the Black-Scholes option pricing model.  Assumptions used in the Black-Scholes model to value options and warrants issued during the six months ended September 30, 2014 were as follows.  There were no options or warrants granted during the six months ended September 30, 2013 that were valued using the Black-Scholes model.
		Six Months Ended	Six Months Ended
		September 30,	September 30,
		2014	2013
	Expected life in years	2.5	NA
	Stock price volatility	170.94% - 214.60%	NA
	Risk free interest rate	0.76% - 1.10%	NA
	Expected dividends	NA	NA
	Forfeiture rate	0%	NA

2_Summary_of_Significant_Accou8

(2) Summary of Significant Accounting Policies: Derivative Liabilities (Policies)	6 Months Ended
	Sep. 30, 2014
Policies	'
Derivative Liabilities	'
	Derivative Liabilities:
	In connection with the private placement of convertible notes beginning in February 2013, the Company became contingently obligated to issue shares of common stock in excess of our then maximum of 200 million shares of authorized common stock under the Company’s certificate of incorporation.  Consequently, the ability to settle these obligations with shares would be unavailable causing these obligations to potentially be settled in cash. This condition created a derivative liability.
	The Company has a sequencing policy regarding share settlement wherein instruments with the earliest issuance date would be settled first. The sequencing policy also considers contingently issuable additional shares, such as those issuable upon a stock split, to have an issuance date to coincide with the event giving rise to the additional shares.
	On December 2, 2013, the Company effected a one-for-twenty reverse stock split of the Company’s issued and outstanding common stock shares.  As a result, the Company’s outstanding shares of common stock and common stock equivalents no longer exceeded the number of authorized shares.  As a result, as of December 2, 2013, these instruments that were accounted for as derivative liabilities were reclassified as equity.
	The Company also has certain warrants and embedded conversion options in notes payable with elements that qualify as derivatives. The warrants have anti-dilution clauses that prevent calculation of the ultimate number of shares that may be issued upon exercise, and four outstanding notes payable that had a variable conversion feature that similarly prevented the calculation of the number of shares into which they were convertible.
	The Company values these warrants and embedded conversion options in notes payable using the Black-Scholes model.  The resulting liability is valued at each reporting date and the change in the liability is reflected as change in derivative liability in the condensed statement of operations.

2_Summary_of_Significant_Accou9

(2) Summary of Significant Accounting Policies: Fair Value of Financial Instruments, Policy (Policies)	6 Months Ended
	Sep. 30, 2014
Policies	'
Fair Value of Financial Instruments, Policy	'
	In determining the appropriate fair value of the derivative liabilities, the Company used the following input levels for its valuation methodology (see Note 6 for more information regarding the Company’s derivative instruments).
			Fair Value		Fair Value Measurements at September 30, 2014
			as of		Using Fair Value Hierarchy
			30-Sep-14		Level 1		Level 2		Level 3
	Liabilities:
	Derivative liability	$	2,013,742	$	-	$	2,013,742	$	-

Recovered_Sheet1

(2) Summary of Significant Accounting Policies: New Accounting Pronouncements (Policies)	6 Months Ended
	Sep. 30, 2014
Policies	'
New Accounting Pronouncements:	'
	New Accounting Pronouncements:
	There are no new significant accounting standards applicable to the Company that have been issued but not yet adopted by the Company as of September 30, 2014, and through the date of this filing.

Recovered_Sheet2

(2) Summary of Significant Accounting Policies: Fair Value of Financial Instruments, Policy: Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis (Tables)	6 Months Ended
	Sep. 30, 2014
Tables/Schedules	'
Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis	'
			Fair Value		Fair Value Measurements at September 30, 2014
			as of		Using Fair Value Hierarchy
			30-Sep-14		Level 1		Level 2		Level 3
	Liabilities:
	Derivative liability	$	2,013,742	$	-	$	2,013,742	$	-

3_Property_and_Equipment_Sched

(3) Property and Equipment: Schedule of Other Assets, Noncurrent (Tables)	6 Months Ended
	Sep. 30, 2014
Tables/Schedules	'
Schedule of Other Assets, Noncurrent	'
			September 30,		March 31,
			2014		2014
			(Unaudited)
	Office equipment	$	65,548	$	61,611
	Computer software		24,166		24,167
	Transportation equipment under construction		657,412		621,802
			747,126		707,580
	Less: accumulated depreciation		(52,765)		(23,173)
		$	694,361	$	684,407

4_Short_Term_Notes_Payable_Sch

(4) Short Term Notes Payable: Schedule of Long-term Debt Instruments (Tables)	6 Months Ended
	Sep. 30, 2014
Tables/Schedules	'
Schedule of Long-term Debt Instruments	'
	Secured promissory notes, dated May 17, 2011 through
	May 17, 2012 to an investor bearing interest at 8% per annum,
	payable on May 17, 2012.	$	-	$		13,333
	Total outstanding notes payable	$	-		$	13,333

5_Convertible_Notes_Payable_Sc

(5) Convertible Notes Payable: Schedule Of Convertible Notes Payable (Tables)	6 Months Ended
	Sep. 30, 2014
Tables/Schedules	'
Schedule Of Convertible Notes Payable	'
			September 30,		March 31,
			2014		2014
			(Unaudited)
	Principal balance of convertible notes payable outstanding	$	3,168,547	$	2,023,000
	Less: discount on convertible notes payable		(381,815)		(601,016)
	Convertible notes payable, net	$	2,786,732	$	1,421,984

5_Convertible_Notes_Payable_Sc1

(5) Convertible Notes Payable: Schedule Of Future Maturities Of Notes Payable (Tables)	6 Months Ended
	Sep. 30, 2014
Tables/Schedules	'
Schedule Of Future Maturities Of Notes Payable	'
			Year Ended
			September 30,
	2015	$	2,950,412
	2016		218,135
	Total	$	3,168,547

6_Derivative_Instruments_Warra

(6) Derivative Instruments: Warrant Value Assumptions Schedule (Tables)	6 Months Ended
	Sep. 30, 2014
Tables/Schedules	'
Warrant Value Assumptions Schedule	'
		Warrants	Notes Payable	Notes Payable& Warrants
		Six Months Ended	Six Months Ended	Six Months Ended
		September 30, 2014	September 30, 2014	September 30, 2013
	Expected life in years	2.9	0.7	0.38 – 9.41 years
	Stock price volatility	193.7% - 272.7%	204.9% - 550.5%	112.3% - 273.7%
	Discount rate	0.13% - 1.78%	0.03% - 0.13%	0.03% - 2.47%
	Expected dividends	None	None	None
	Forfeiture rate	0%	0%	0%

7_Equity_Schedule_of_Stockhold

(7) Equity: Schedule of Stockholders' Equity Note, Warrants or Rights (Tables)	6 Months Ended
	Sep. 30, 2014
Tables/Schedules	'
Schedule of Stockholders' Equity Note, Warrants or Rights	'
	Warrant	Number of shares	Life outstanding	Exercise price
	602	1,666,667	3 years	0.001
	603	833,334	3 years	0.001
	604	1,666,667	3 years	0.001
	605	166,667	3 years	0.001
	606	416,667	3 years	0.001
	607	1,666,667	3 years	0.001
	608	250,000	3 years	0.001
	609	63,333	3 years	0.001
	610	25,000	3 years	0.001
	Total	6,755,001

8_Stock_Option_Plan_Schedule_o

(8) Stock Option Plan: Schedule of Stock Option Activity (Tables)	6 Months Ended
	Sep. 30, 2014
Tables/Schedules	'
Schedule of Stock Option Activity	'
	The following is a summary of the Company’s stock option activity:
					Weighted-
				Weighted-	Average
				Average	Remaining		Aggregate
				Exercise	Contractual		Intrinsic
		Options		Price	Life (Years)		Value
	Outstanding at March 31, 2014	100,000	$	10.00	4.59	$	-
	Granted	14,116,791		0.0001			2,671,613
	Exercised	(11,950,718)		0.0001			1,472,431
	Outstanding at September 30, 2014 (unaudited)	2,266,073	$	0.44	4.77	$	21,444
	Vested at September 30, 2014	2,266,073	$	0.44	4.77	$	21,444
	Exercisable at September 30, 2014	2,266,073	$	0.44	4.77	$	21,444

8_Stock_Option_Plan_Schedule_o1

(8) Stock Option Plan: Schedule of Stock Options Outstanding and Exercisable (Tables)	6 Months Ended
	Sep. 30, 2014
Tables/Schedules	'
Schedule of Stock Options Outstanding and Exercisable	'
	Options Outstanding and Exercisable
		Weighted		Weighted
		Average		Average
	Number	Remaining		Exercise
	of Shares	Life (Years)		Price
	100,000	4.09	$	10.00
	2,166,073	4.8	$	0.0001
	2,266,073	4.77	$	0.44

1_Organization_and_Basis_of_Pr1

(1) Organization and Basis of Presentation (Details) (USD $)	3 Months Ended		6 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Details	'	'	'	'
Net loss	$2,430,583	($1,400,773)	$6,984,301	$1,815,774
Accumulated Other Comprehensive Income (Loss), Net of Tax	38,611,947	'	38,611,947	'
Negative working capital	5,168,558	'	5,168,558	'
Convertible Notes Payable Outstanding	$3,168,547	'	$3,168,547	'

Recovered_Sheet3

(2) Summary of Significant Accounting Policies: Basic and Diluted Loss Per Share (Details) (USD $)	Sep. 30, 2014	Mar. 31, 2014	Sep. 30, 2014	Sep. 30, 2014
			Debt	Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	'	'	2,266,073	9,070,650
Principal balance of convertible notes payable outstanding	$3,168,547	$2,023,000	'	'

Recovered_Sheet4

(2) Summary of Significant Accounting Policies: Fair Value of Financial Instruments, Policy: Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis (Details) (USD $)	Sep. 30, 2014	Mar. 31, 2014	Sep. 30, 2013	Mar. 31, 2013
Derivative liability	$2,013,742	$1,198,018	$2,294,077	$3,181,537
Fair Value, Inputs, Level 2	'	'	'	'
Derivative liability	$2,013,742	'	'	'

3_Property_and_Equipment_Sched1

(3) Property and Equipment: Schedule of Other Assets, Noncurrent (Details) (USD $)	Sep. 30, 2014	Mar. 31, 2014
Property, Plant and Equipment, Gross	$747,126	$707,580
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	-52,765	-23,173
Property and equipment, net of accumulated depreciation	694,361	684,407
Computer Software, Intangible Asset	'	'
Property, Plant and Equipment, Gross	24,166	24,167
Office Equipment	'	'
Property, Plant and Equipment, Gross	65,548	61,611
Railroad Transportation Equipment	'	'
Property, Plant and Equipment, Gross	$657,412	$621,802

4_Short_Term_Notes_Payable_Sch1

(4) Short Term Notes Payable: Schedule of Long-term Debt Instruments (Details) (USD $)	Mar. 31, 2014
Details	'
Secured promissory notes, dated May 17, 2011 through May 17, 2012 to an investor bearing interest at 8% per annum, payable on May 17, 2012	$13,333
Short term notes payable	$13,333

5_Convertible_Notes_Payable_Sc2

(5) Convertible Notes Payable: Schedule Of Convertible Notes Payable (Details) (USD $)	Sep. 30, 2014	Mar. 31, 2014
Details	'	'
Principal balance of convertible notes payable outstanding	$3,168,547	$2,023,000
Convertible notes payable discount	-381,815	-601,016
Convertible Notes Payable, Noncurrent	$2,786,732	$1,421,984

5_Convertible_Notes_Payable_Sc3

(5) Convertible Notes Payable: Schedule Of Future Maturities Of Notes Payable (Details) (USD $)	Sep. 30, 2014
Details	'
Long-term Debt of Registrant, Maturities, Repayments of Principal in Remainder of Fiscal Year	$2,950,412
Long-term Debt of Registrant, Maturities, Repayments of Principal in Rolling Year Two	218,135
Total notes payable	$3,168,547

6_Derivative_Instruments_Warra1

(6) Derivative Instruments: Warrant Value Assumptions Schedule (Details) (USD $)	6 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Details	'	'
Warrant Value Assumptions Expected Life	'2.9	'
Notes Payable Assumptions Expected Life	'0.7	'
Notes Payable & Warrants Assumptions Expected Life	'	'0.38 – 9.41
Warrant Value Assumptions Stock Price Volatility	'193.7% - 272.7%	'
Notes Payable Assumptions Stock Price Volatility	'204.9% - 550.5%	'
Notes Payable & Warrants Assumptions Stock Price Volatility	'	'112.3% - 273.7%
Warrant Value Assumption Discount Rate	'0.13% - 1.78%	'
Notes Payable Assumption Discount Rate	'0.03% - 0.13%	'
Notes Payable & Warrants Assumption Discount Rate	'	'0.03% - 2.47%
Warrant Value Assumptions Expected Dividends	$0	'
Notes Payable Assumptions Expected Dividends	0	'
Notes Payable & Warrants Assumptions Expected Dividends	'	$0
Warrant Value Assumptions Forfeiture Rate	0.00%	'
Notes Payable Assumptions Forfeiture Rate	0.00%	'
Notes Payable & Warrants Assumptions Forfeiture Rate	'	0.00%

7_Equity_Details

(7) Equity (Details) (USD $)	6 Months Ended		7 Months Ended	18 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2014	Mar. 31, 2014
Details	'	'	'	'	'
Common stock shares authorized	500,000,000	'	'	500,000,000	500,000,000
Shares issued from converted debt	'	'	'	374,910	'
Convertible notes payable and accrued interest	'	'	$374,933	'	'
Shares converted held by related party entity	'	200,000	'	'	'
Convertible note payable held by related party entity	'	200,000	'	'	'
Shares issued as payment of notes payable	8,272,697	'	'	'	'
Outstanding notes payable and accrued interest	135,132	'	'	135,132	'
Shares issued for services	12,050,718	432,000	'	'	'
Services expense	$2,671,898	$188,731	'	'	'
Shares issued for warrants	'	9,823	'	'	'
Shares issued for private placement	11,950,718	'	'	'	'
Warrants issued in connection with convertible notes	'	880,000	'	'	'
Warrants issued for payments of commissions	'	238,000	'	'	'
Warrants issued for payments of directors' services	'	100,000	'	'	'

8_Stock_Option_Plan_Details

(8) Stock Option Plan (Details) (USD $)	6 Months Ended
	Sep. 30, 2014	Mar. 31, 2014
Details	'	'
Grant of Stock Options Under Plan	1,000,000	'
Outstanding Employee Stock Options	100,000	100,000
Grant Date Market Price of Company's Stock	$10	'

9_Related_Party_Transactions_D1

(9) Related Party Transactions Disclosure (Details) (USD $)	6 Months Ended
	Sep. 30, 2014
Details	'
Proceeds from notes payable - related parties	$59,000